Global 510(k) approvals (2005-2025) and India's presence-A Market Analysis

Global 510(k) approvals (2005-2025) and India's presence-A Market Analysis
30-Oct-2025

Global 510(k) Approvals (2005–2025): Market Analysis

Introduction

The U.S. FDA’s 510(k) clearance pathway is a critical regulatory mechanism allowing medical device manufacturers to enter the American market by demonstrating substantial equivalence to existing approved devices. This report presents a global market analysis of 510(k) approvals from 2005 to 2024, emphasizing India’s role and key contributors from the region.

Global Overview of 510(k) Approvals

Between 2005 and 2025 (May), a total of 63,100 510(k) approvals were granted worldwide. These clearances represent a wide range of medical devices from diagnostic equipment and surgical tools to implantables and AI-powered diagnostic software.

The graph illustrates the number of FDA 510(k) obtained globally between 2005 and 2025.

While the major contributor remains the United States (68.0%), countries such as China (7.7%), South Korea (2.9%), Germany (2.9%), and Taiwan (2.0%) also play an essential role. India (0.34%),though comparatively smaller, has demonstrated consistent and strategic participation in the global regulatory ecosystem.

India's Contribution to Global 501(K) Activity 

India accounted for 215-510(k) clearances over the two-decade span, making up approximately 0.34% of the global total. While the percentage is modest, it represents a steady increase in Indian firms engaging with the U.S. regulatory pathway, a signal of maturing capabilities in compliance, innovation, and global competitiveness.

Key Statistics:

  • Total Global Approvals (2005–2025): 63,100

  • India’s Approvals: 215

  • India’s Share: 0.34%

While early years saw relatively few submissions, there's a clear and steady rise post-2018, peaking around 2022–2024. The trend showcases India's growing footprint in the global medical device landscape.

Indian Companies by 501(K) Approvals

Notable Indian companies that have successfully received 510(k) approvals between 2005 and 2024 include Auxein Medical Private Limited, Meril Endo-Surgery, Prevest Denpro, Qure.ai Technologies, Allengers Medical Systems, Healthium Medtech, and Poly Medicure, among others. These firms reflect the growing regulatory engagement and innovation capacity within India’s MedTech sector.


Key Statistics:

India has secured a total of 215 FDA 510(k) approvals from 2005 to 2025. Remarkably, 10 leading Indian companies account for approximately 39% of these clearances, highlighting a concentrated contribution from a few key players within the country’s MedTech landscape.

Analysis & Outlook:

India’s limited share in global 510(k) approvals can be attributed to several historical and structural factors:

  • A smaller base of export-oriented MedTech firms

  • High compliance and documentation burdens of the FDA process

  • Lack of institutional regulatory support in earlier years

However, notable trends suggest acceleration:

  • Growing presence of AI-powered diagnostics (e.g., Qure.ai)

  • Improved manufacturing capabilities and GMP compliance

  • Government initiatives like Make in India and PLI schemes boosting MedTech exports

As Indian manufacturers increasingly invest in regulatory affairs teams and international certifications, their participation in 510(k) submissions is expected to rise.

While India currently contributes a small fraction to global 510(k) approvals, it is steadily positioning itself as an emerging force in the medical device sector.

The Role of easyQ Solutions

At easyQ Solutions, we support this growing momentum. We have built easyQ eQMS, a modern, cloud-native Quality Management System designed specifically for fast-growing medical device companies. Whether you are a startup or a global manufacturer, our eQMS simplifies compliance with:

ISO 13485

  21 CFR Part 820 & Part 11 and other global requirements.

With built-in workflows aligned to global standards, easyQ eQMS is easy to implement and scale, enabling your device to enter into the market faster.

We are more than just software providers. As a regulatory technology company, we offer expert guidance and submission support for US FDA, EU MDR/IVDR, CDSCO, and other global regulatory bodies empowering MedTech innovators to succeed on the global stage.

Ready to take your device global? Let’s Connect

Contact us at: reachus@easyqsolutions.com today to learn more.

easyQ Editorial Team

easyQ Editorial Team

Provides expert insights on medical device quality management, regulatory compliance, and eQMS solutions to help MedTech companies simplify compliance and improve quality processes.

Start Your Smart Compliance Journey

Get expert guidance and simplify your compliance process today — talk to our team about how easyQ fits your QMS.

Talk to Our Experts
easyQ compliance experts